CLINICAL TRIALS PROFILE FOR DWP14012
✉ Email this page to a colleague
Clinical Trials for DWP14012
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT02757144 ↗ | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 1 | This is a dose block-randomized, double-blind, placebo- and active-controlled, single and multiple dosing, dose-escalation clinical phase 1 trial to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of DWP14012 after oral administration in healthy male volunteers. |
| NCT03184324 ↗ | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 2 | The purpose of this study is to determine the efficacy and safety of DWP14012 compared to esomeprazole in the treatment of erosive gastroesophageal reflux disease classified as Los Angeles(LA) classification grades A to D. |
| NCT03487562 ↗ | Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 1 | This is a randomized, open-label, multiple dose, two-part phase I clinical trial to compare the pharmacokinetics, pharmacodynamics and safety/tolerability of DWP14012 after administrations of DWP14012 alone and combinations of DWP14012, Clarithromycin and Amoxicillin in healthy male subjects |
| NCT03574415 ↗ | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 1 | To evaluate the safety and tolerability of single and multiple ascending oral doses of DWP14012 in healthy Japanese, Caucasian and Korean subjects |
| NCT03736369 ↗ | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | Completed | Daewoong Pharmaceutical Co. LTD. | Phase 3 | The purpose of study is to confirm the efficacy of DWP14012 Xmg, Once daily, compared to esomeprazole 40mg in patients with erosive gastroesophageal reflux disease. |
| NCT03811080 ↗ | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease | Unknown status | Daewoong Pharmaceutical Co. LTD. | Phase 3 | The purpose of this study is to demonstrate the superiority of efficacy of DWP14012, once daily (QD), compared to placebo in patients with non-erosive reflux disease at Week 4. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for DWP14012
Condition Name
Clinical Trial Locations for DWP14012
Clinical Trial Progress for DWP14012
Clinical Trial Phase
Clinical Trial Sponsors for DWP14012
Sponsor Name
